PMID: 6405475Mar 1, 1983Paper

Infections caused by Pseudomonas aeruginosa

Reviews of Infectious Diseases
G P BodeyL Jadeja

Abstract

Pseudomonas aeruginosa has emerged as an important pathogen during the past two decades. It causes between 10% and 20% of infections in most hospitals. Pseudomonas infection is especially prevalent among patients with burn wounds, cystic fibrosis, acute leukemia, organ transplants, and intravenous-drug addiction. P. aeruginosa is a common nosocomial contaminant, and epidemics have been traced to many items in the hospital environment. Patients who are hospitalized for extended periods are frequently colonized by this organism and are at increased risk of developing infection. The most serious infections include malignant external otitis, endophthalmitis, endocarditis, meningitis, pneumonia, and septicemia. The likelihood of recovery from pseudomonas infection is related to the severity of the patient's underlying disease process. The introduction of the antipseudomonal aminoglycosides and penicillins has improved substantially the prognosis of these infections. Ticarcillin and carbenicillin have been especially beneficial in neutropenic patients; however, prompt institution of therapy is mandatory for optimal benefit. Many new drugs with antipseudomonal activity, including penicillins, cephalosporins, and other beta-lactams, ha...Continue Reading

Citations

Jun 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A TalarminY Buisson
Sep 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C L PohL Tay
Aug 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F VázquezF J Méndez
Feb 1, 1986·European Journal of Clinical Microbiology·N X ChinH C Neu
Apr 1, 1985·European Journal of Clinical Microbiology·S J CryzR Germanier
Apr 1, 1985·European Journal of Clinical Microbiology·A T McManusB A Pruitt
Oct 1, 1987·European Journal of Clinical Microbiology·M Giacca, C Monti-Bragadin
Jul 20, 1999·Diseases of the Colon and Rectum·E FreudM Zer
Jan 1, 1989·Folia Microbiologica·R VasishtaM Saxena
Jun 2, 2009·Current Microbiology·Muayad M AbboudAmjad Al Tarawneh
Aug 18, 2012·World Journal of Microbiology & Biotechnology·Xiaoxiang LiuXiaoqiang Chen
Jun 1, 2007·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·P K MajiB B Mukhopadhyay
Aug 9, 1985·The American Journal of Medicine·J L BlumerM D Reed
Dec 15, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·H Maeda, A Molla
Mar 1, 1993·The International Journal of Biochemistry·M ChristofidouE D Anastassiou
Jan 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·D R VidalJ Banchereau
Jun 1, 1985·Vaccine·F Dorner, J L McDonel
Jul 1, 1991·Vaccine·E S StanislavskyV M Rusanov
Jan 15, 1996·FEMS Microbiology Letters·J Goranson, D W Frank
Aug 4, 1993·Biochimica Et Biophysica Acta·M M KhanT Kambara
Oct 16, 2013·Protein Expression and Purification·Wangluo ZhangHuaxing Zhu
Jan 25, 2003·Burns : Journal of the International Society for Burn Injuries·Huey-Fang ShangSung-Ling Yeh
Oct 3, 2003·Microbial Pathogenesis·Elisabeth SonnleitnerUdo Bläsi
Jun 17, 2000·International Journal of Antimicrobial Agents·E SwiatloL S McDaniel
Jul 3, 2003·Journal of the American Society for Mass Spectrometry·Tina GuinaKimberly A Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.